Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Contact Pharma in Focus

If you would like to know more about Pharma in Focus then write, email or phone us.

Postal Address: Suite 202
117 Old Pittwater Road
Brookvale NSW 2100
Advertising: +61 2 9938 4381
Editorial: +61 2 9939 0981
Subscriptions & Access: +61 2 9939 1881
Fax: +61 2 9938 5681
Email: info@pharmainfocus.com.au

If you would like specific information then please fill in the form below and send it to us.

Special Report
PBAC reveals giant November agenda
As anticipated, the November 2016 PBAC agenda is huge with 36 major submissions and 26 minor but comparatively few on the parallel processing track.
Approvals Action
Apotex sets sights on $146m Novartis drug
Apotex has registered two new brands for one of Novartis' biggest selling products as patent expiry looms.
PBAC Outcomes
PBAC in major denial mode
The PBAC either rejected or deferred 16 major submissions and resubmissions at its July meeting with another three parallel submissions held off because TGA data was insufficient; only seven majors were recommended for listing.
Pipeline Monitor
Gilead wins speedy review for HIV hope
Gilead has filed its latest drug combo in the US with hopes of maintaining HIV sales as hep C blockbusters fall back.